JESSICA HAYNIE: Open Payments
NPI 1316399108 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 49 payments from 10 companies in 2025. Trend: 2023 $653 · 2024 $682 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 35 | $362 |
| Otsuka America Pharmaceutical, Inc. | 2 | $125 |
| Calliditas Therapeutics US Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $107 |
| Novo Nordisk Inc | 1 | $102 |
| Ardelyx, Inc. | 4 | $97 |
| Inspire Medical Systems, Inc. | 2 | $66 |
| AKEBIA THERAPEUTICS INC | 1 | $27 |
| Travere Therapeutics, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: VELPHORO, TARPEYO, VRAYLAR, REXULTI, Ozempic, IBSRELA, INSPIRE, Auryxia.
Industry payments across AL — which companies pay providers there.
